Free public records show Swedish Orphan Biovitrum in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Swedish Orphan Biovitrum or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
12 active studies led by Swedish Orphan Biovitrum, of 82 in all
Source: ClinicalTrials.gov, Studies with Swedish Orphan Biovitrum (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Swedish Orphan Biovitrum leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Swedish Orphan Biovitrum or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Swedish Orphan Biovitrum: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Swedish Orphan Biovitrum is in.
Stories on the topics Swedish Orphan Biovitrum works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Iron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is…
Read
Vitamin B12 comes almost only from animal foods. Vegetarians, older adults and people on some medicines are…
ReadSearch all reports for Swedish Orphan Biovitrum All companies